Family Office Of America (FOFA) Gains from Investment Securities (2021 - 2026)
Family Office Of America's (FOFA) quarterly Gains from Investment Securities came in at $10127.0 in Q1 2026, down 86.05% year-on-year from $72575.0 in Q1 2025, and down 91.56% quarter-over-quarter from $120000.0 in Q4 2025.
Family Office Of America (FOFA) Gains from Investment Securities (2021 - 2026) Analysis & Trends
Family Office Of America has disclosed Gains from Investment Securities across 6 years of filings, most recently posting $10127.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $10127.0, down 86.05% year-over-year; the trailing twelve-month figure through Mar 2026 was $111242.0 (up 30.27% YoY), and the FY2025 annual result was $120000.0, changed 0.0% from the prior year.
- Gains from Investment Securities came in at $10127.0 for Q1 2026 at Family Office Of America, down from $120000.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $1.6 million in Q2 2023 to a low of -$1.6 million in Q4 2023.
- The 5-year median for Gains from Investment Securities is $23052.0 (2022), against an average of $50629.9.
- Peak annual rise in Gains from Investment Securities reached 1237.67% in 2023, while the deepest fall reached 7007.82% in 2023.
- Family Office Of America's Gains from Investment Securities stood at $23052.0 in 2022, then sank by 7007.82% to -$1.6 million in 2023, then jumped by 107.54% to $120000.0 in 2024, then changed by 0.0% to $120000.0 in 2025, then plunged by 91.56% to $10127.0 in 2026.
- The last three Gains from Investment Securities figures came in at $10127.0 (Q1 2026), $120000.0 (Q4 2025), and $14270.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn |
| 10 | Family Office Of America | - | - | 783,126.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,127.00 |
| Mar 31, 2026 | 10,127.00 |
| Dec 31, 2025 | 120,000.00 |
| Dec 31, 2025 | 120,000.00 |
| Sep 30, 2025 | 14,270.00 |
| Sep 30, 2025 | 14,270.00 |
| Jun 30, 2025 | 14,270.00 |
| Jun 30, 2025 | 14,270.00 |
| Mar 31, 2025 | 72,575.00 |
| Mar 31, 2025 | 72,575.00 |
| Dec 31, 2024 | 120,000.00 |
| Dec 31, 2024 | 120,000.00 |
| Dec 31, 2023 | -1.59 Mn |
| Dec 31, 2023 | -1.59 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Jun 30, 2023 | 1.61 Mn |
| Mar 31, 2023 | 17,531.00 |
| Mar 31, 2023 | 17,531.00 |
| Dec 31, 2022 | 23,052.00 |
| Dec 31, 2022 | 23,052.00 |